Steatosis in HIV Study - Clinical Trial
What is the Purpose of this Study?
We are doing this study to find out how common it is for people who have HIV to accumulate excess fat in the liver or develop steatotic liver disease.
What is the Condition Being Studied?
Human Immunodeficiency Virus (HIV) and Steatotic Liver Disease
Who Can Participate in the Study?
Adults ages 18+ who:
- Are diagnosed with HIV
- Have been on antiviral HIV treatment for at least 6 months
For more information about who can join this study, contact the study team at 919-668-3199.
Age Group
Adults
What is Involved?
If you agree to join this study, you will:
- Visit our clinic 1 time
- Have a physical exam
- Have a blood draw
- Have a procedure called Fibroscan (a painless, ultrasound-based test to check for liver fat or scarring)
- Answer questionnaires
Study Details
Full Title
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) / ?Prevalence and Predictors of Hepatic Steatosis in Persons Living with HIV (Steatosis in HIV Study)?
Principal Investigator
Infectious Disease Specialist
Protocol Number
IRB:
PRO00107920
NCT:
NCT04795219
Phase
Phase
N/A
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment